Cartesian Therapeutics, a late clinical-stage biotech company, granted a new employee options to purchase 50,000 shares at $6.34 each as an inducement to join the company. The options vest over four years and have a ten-year term. This move aims to attract talent to support the company's development of cell therapies for autoimmune diseases, including its lead CAR-T therapy in clinical trials. The grant was approved by the board under Nasdaq rules for employment inducements.
Cartesian Therapeutics' new employment inducement grant provides context for readers following biotech developments. For readers following the Health sector, here is Pluang's market snapshot as of Nov 03, 2026 19:02 WIB: Out of 150 priced Health-sector US stocks tradable on Pluang, 74 rose and 69 fell today. Notable movers include ADMA Biologics Inc (ADMA) at USD 11.35 with a 1-day change of +2.62% and a typical hold time on Pluang of 20 days with balanced order activity, Dyne Therapeutics Inc. (DYN) at USD 16.86 down -2.54% with a 9-day typical hold time, and Definium Therapeutics Inc. (DFTX) at USD 32.82 up +2.34% with a 14-day typical hold time.
Anavex Life Sciences appointed Terrie Kellmeyer, Ph.D., as President and CEO, also joining the Board. Kellmeyer, with over 30 years in biopharma, has led the company through key clinical milestones including FDA clearance for Fragile X syndrome trial...
Cardiff Oncology, a clinical-stage biotech company focusing on cancer therapies via PLK1 inhibition, announced it will present at the UBS Global Biopharma Conference on November 16-17, 2026. The company's CEO, Mani Mohindru, will deliver a fireside c...
Seyond Inc is enhancing its smart city solutions by integrating advanced LiDAR 3D sensing with AI-powered analytics and collaborations with Dell Technologies, NVIDIA, and AMSYS. This expansion supports improved safety, transportation, and infrastruct...
Stella-Jones Inc. announced a teleconference on November 4, 2026, at 10:00 AM EST to discuss its third-quarter 2026 financial results. The event is open to investors, analysts, and interested parties, with live streaming and phone access provided. A ...
Stella-Jones Inc. announced a conference call for November 4, 2026, at 10:00 AM EST to discuss its third quarter 2026 financial results. The call is open to investors, analysts, and interested parties and will be webcast live with a recording availab...
